Clinical Trials List
2020-06-01 - 2026-12-31
Phase III
Recruiting8
ICD-9185
Malignant neoplasm of prostate
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Yung-Chin Lee 未分科
- Sheng-Chen Wen Division of Urology
- Ching-Chia Li Division of Urology
- Hung-Lung Ke Division of Urology
- Hsiang Ying Lee Division of Urology
- 阮雍順 Division of Urology
- Tsung-Yi Huang Division of Urology
- Tsu-Ming Chien Division of Urology
- 黃俊農 未分科
- Shu-Pin Huang 未分科
- 李政學 未分科
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yen-Hwa Chang Division of Urology
- Tzu-Hao Huang Division of Urology
- I-Shen Huang Division of Urology
- Chih-Chieh Lin Division of Urology
- 沈書慧 Division of Radiology
- William Huang Division of Urology
- 陳威任 Division of Urology
- Tzu-Ping Lin Division of Urology
- Chien-Hsin Ting Division of Nuclear Medicine
- Yi-Hsiu Huang Division of Urology
- 潘競成 Division of General Surgery
- Tzu-chun Wei Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Su-Peng Yeh Division of Hematology & Oncology
- Wei-Ching Lin Division of Radiology
- Po-Jen Hsiao Division of Urology
- Che-Hung Lin Division of Hematology & Oncology
- Yu-De Wang Division of Urology
- Po-Fan Hsieh Division of Urology
- Chao-Hsiang Chang Division of Urology
- Yi-Huei Chang Division of Urology
- Chi-Rei Yang Division of Urology
- Hsi-Chin Wu Division of Urology
- Han Chang Division of General Surgery
- Ching-Chan Lin Division of Hematology & Oncology
- 謝德鈞 Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yung-Chang Lin Division of Hematology & Oncology
- 陳東藝 Division of Cardiovascular Diseases
- Hong-Cheng Gan Division of Hematology & Oncology
- Chen Pang Hou Division of Hematology & Oncology
- 黃文冠
- Yuan-Cheng Chu Division of Hematology & Oncology
- Kai-Jie Yu Division of Hematology & Oncology
- Rita cheng Division of Hematology & Oncology
- Po-Jung Su Division of Hematology & Oncology
- I-hung Shao Division of Hematology & Oncology
- 張境夫 Division of Hematology & Oncology
- 黃亮鋼 Division of Hematology & Oncology
- PO-HUNG LIN Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
1000 participants
